Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial

NCT07699107 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Juvenile Idiopathic Arthritis Associated Uveitis
Uveitis, Anterior

Interventions

BIOLOGICAL: Adalimumab/Biosimilar

Sponsor

Nisha Acharya

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]